Schwabe Pharma Asia Pacific
to top

31st ECNP Congress – The future of CNS treatment in Barcelona

06 Oct 2018
Schwabe Pharma Asia Pacific (SPAP) participated in 31st ECNP Congress from 6th to 9th October 2018 in Barcelona, Spain. Other than an exhibition booth featuring Tebonin®, Schwabe Group organized a Satellite Symposium on Mild cognitive impairment (MCI) : “Age-associated burden or treatable disease” on 8th Oct, 2018."